BioOutsource will open a new Biosimilar Center of Excellence in Scotland.
BioOutsource, a leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, will open a new Biosimilar Center of Excellence in Glasgow. The new facility will double the company’s capacity for the analysis of biosimilar monoclonal antibodies.
The Biosimilar Center of Excellence is located on the West of Scotland Science Park in Glasgow, adjacent to the existing BioOutsource facility. The new operation will consist of approximately 40 laboratory and R&D scientists creating an estimated 20 new jobs.
Source: BioOutsource
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.